Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard J Epstein

Showing results (1-10 of 66) with videos related to

Pageof 7
Sort By:
Lancet (London, England)|June 6, 2003
Hormonal contraception and cervical cancerRichard J Epstein
Cancer Metastasis Reviews|September 6, 2007
VEGF signaling inhibitors: more pro-apoptotic than anti-angiogenicRichard J Epstein
European Journal of Cancer (Oxford, England : 1990)|March 31, 2009
TNM: therapeutically not mandatoryRichard J Epstein
Seminars in Oncology|February 23, 2010
Digitization and its discontents: future shock in predictive oncologyRichard J Epstein
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|August 23, 2021
The secret identities of TMPRSS2: Fertility factor, virus trafficker, inflammation moderator, prostate protector and tumor suppressorRichard J Epstein
Clinical Breast Cancer|August 8, 2009
Visual impairment in myopic patients with breast cancer receiving adjuvant therapy with aromatase inhibitorsRichard J Epstein
European Journal of Cancer (Oxford, England : 1990)|October 15, 2005
Primary prevention of human papillomavirus-dependent neoplasia: no condom, no sexRichard J Epstein
BMC Medical Education|January 10, 2004
Learning from the problems of problem-based learningRichard J Epstein
Future Healthcare Journal|October 3, 2023
To find fault is easy, to find no-fault is fairRichard J Epstein
Nature Reviews. Cancer|November 2, 2004
The CXCL12-CXCR4 chemotactic pathway as a target of adjuvant breast cancer therapiesRichard J Epstein
Pageof 7

Showing results (1-10 of 66) with videos related to

Sort By:
Pageof 7
Lancet (London, England)|June 6, 2003
Hormonal contraception and cervical cancerRichard J Epstein
Cancer Metastasis Reviews|September 6, 2007
VEGF signaling inhibitors: more pro-apoptotic than anti-angiogenicRichard J Epstein
European Journal of Cancer (Oxford, England : 1990)|March 31, 2009
TNM: therapeutically not mandatoryRichard J Epstein
Seminars in Oncology|February 23, 2010
Digitization and its discontents: future shock in predictive oncologyRichard J Epstein
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|August 23, 2021
The secret identities of TMPRSS2: Fertility factor, virus trafficker, inflammation moderator, prostate protector and tumor suppressorRichard J Epstein
Clinical Breast Cancer|August 8, 2009
Visual impairment in myopic patients with breast cancer receiving adjuvant therapy with aromatase inhibitorsRichard J Epstein
European Journal of Cancer (Oxford, England : 1990)|October 15, 2005
Primary prevention of human papillomavirus-dependent neoplasia: no condom, no sexRichard J Epstein
BMC Medical Education|January 10, 2004
Learning from the problems of problem-based learningRichard J Epstein
Future Healthcare Journal|October 3, 2023
To find fault is easy, to find no-fault is fairRichard J Epstein
Nature Reviews. Cancer|November 2, 2004
The CXCL12-CXCR4 chemotactic pathway as a target of adjuvant breast cancer therapiesRichard J Epstein
Pageof 7